Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chimera Antigen Receptor (CAR)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07234110
What this trial is testing

CD5 CART for the Treatment of Relapsed and Refractory CD5 Hematological Tumors

Who this might be right for
Relapsed and Refractory CD5 Hematological Tumors
Institute of Hematology & Blood Diseases Hospital, China 18
Early research (Phase 1)Looking for participantsNCT06347068
What this trial is testing

Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells

Who this might be right for
Breast CancerRelapseResistant Cancer+1 more
UNC Lineberger Comprehensive Cancer Center 42
Early research (Phase 1)Ended earlyNCT02664363
What this trial is testing

EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma

Who this might be right for
GlioblastomaGliosarcoma
Daniel Landi 3
Very early researchUnknownNCT04977193
What this trial is testing

Evaluate the Safety and Efficacy of ly011 Cell Injection in the Treatment of Advanced Gastric Adenocarcinoma

Who this might be right for
Advanced Gastric Adenocarcinoma
Shanghai Longyao Biotechnology Inc., Ltd. 18
Early research (Phase 1)Looking for participantsNCT06875063
What this trial is testing

GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHL

Who this might be right for
Non-hodgkin LymphomaRefractory LymphomaChimeric Antigen Receptor T-cell
The First Affiliated Hospital of Xiamen University 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07729826
What this trial is testing

C-CAR168 CAR T-Cell Therapy for the Treatment of Lupus Nephritis Refractory to Standard Therapy

Who this might be right for
Lupus Nephritis (LN)Systemic Lupus Erythematosus (SLE)Autoimmune Diseases
AbelZeta Inc. 50
Early research (Phase 1)Looking for participantsNCT06686524
What this trial is testing

Clinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes (UCAR-T) for the Treatment of Refractory Juvenile Dermatomyositis (RJDM)

Who this might be right for
Dermatomyositis, JuvenileDermatomyositis
Chongqing Precision Biotech Co., Ltd 18
Very early researchStudy completedNCT06827886
What this trial is testing

GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma

Who this might be right for
Alveolar Soft Part Sarcoma
AHS Cancer Control Alberta 1
Early research (Phase 1)UnknownNCT01818323
What this trial is testing

Phase I Trial: T4 Immunotherapy of Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
King's College London 30
Testing effectiveness (Phase 2)WithdrawnNCT02723942
What this trial is testing

CAR-T Cell Immunotherapy for HCC Targeting GPC3

Who this might be right for
GPC3 Positive Hepatocellular CarcinomaCAR-T Cell Immunotherapy
Fuda Cancer Hospital, Guangzhou
Early research (Phase 1)Temporarily pausedNCT07181720
What this trial is testing

CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Lung CancerAnaplastic Thyroid Carcinomas+3 more
Chongqing Precision Biotech Co., Ltd 90
Testing effectiveness (Phase 2)Looking for participantsNCT02830724
What this trial is testing

Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

Who this might be right for
Pancreatic CancerRenal Cell CancerBreast Cancer+2 more
National Cancer Institute (NCI) 124
Early research (Phase 1)Study completedNCT03919526
What this trial is testing

Anti-CD19/CD22 Bispecific Chimeric Antigen Receptor（CAR)-T Cell Therapy for Measurable Residual Disease(MRD) Positive ALL

Who this might be right for
MRD-positiveAcute Lymphoblastic Leukemia
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 19
Large-scale testing (Phase 3)Looking for participantsNCT06652633
What this trial is testing

Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies

Who this might be right for
Hematological Malignancies
Lakefront Biotherapeutics NV 546
Early research (Phase 1)UnknownNCT02456350
What this trial is testing

Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies

Who this might be right for
Chronic Lymphocytic LeukemiaAcute Lymphocytic LeukemiaLymphoma
Shenzhen Second People's Hospital 36
Early research (Phase 1)Looking for participantsNCT05544526
What this trial is testing

CAR T Cells to Target GD2 for DMG

Who this might be right for
Diffuse Midline Glioma, H3 K27M-Mutant
University College, London 12
Testing effectiveness (Phase 2)Ended earlyNCT04340154
What this trial is testing

Study of Sequential CAR-T Cell Treating Leukemia Children

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia, in RelapseRefractory Acute Lymphoid Leukemia
Beijing Boren Hospital 81
Early research (Phase 1)Ended earlyNCT03448978
What this trial is testing

Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma

Who this might be right for
Multiple Myeloma
Cartesian Therapeutics 32
Early research (Phase 1)Ended earlyNCT06197178
What this trial is testing

LCAR-G08 in Subjects With Advanced Gastrointestinal Tumors Expressing Guanylyl Cyclase C (GCC)

Who this might be right for
Advanced Gastrointestinal Tumors
Peking University 17
Testing effectiveness (Phase 2)Study completedNCT05634785
What this trial is testing

CD30 CAR for CD30+ NSGCT

Who this might be right for
Germ Cell TumorNonseminomatous Germ Cell Tumor
UNC Lineberger Comprehensive Cancer Center 2
Next Page